Eurofins Viracor offers a comprehensive suite of specialized laboratory tests designed to support complex clinical decision-making. These assays span immunology, infectious diseases, oncology, and transplant monitoring.
Clinicians rely on these precise, high-sensitivity tests to guide therapy and track patient progress. This test menu serves as a detailed reference to optimize patient care plans.
Each entry in the menu includes specimen requirements, turnaround times, and clinical utility. The menu is organized by specialty area to facilitate rapid navigation.
Updated regularly, it reflects the latest advancements in laboratory medicine. Clinicians and laboratorians can easily access the desired test information.
Overview of Services
Eurofins Viracor’s laboratory services are accredited under CLIA and CAP standards. The laboratory employs advanced technologies such as next-generation sequencing, multiplex PCR, and mass spectrometry.
This broad platform enables detection of rare pathogens, immune markers, and genetic variants. Stringent quality controls ensure consistent, reliable performance.
The laboratory is staffed by doctoral-level scientists and board-certified pathologists. Each test undergoes rigorous validation to meet regulatory requirements.
Turnaround times vary by assay complexity but are clearly indicated in the menu. A dedicated client support team is available to assist with test selection and logistics.
Test Categories
Tests are grouped according to clinical discipline for efficiency. Categories include Transplant Diagnostics, Infectious Disease Panels, Autoimmune Profiles, and Oncology Assays.
This structure enables providers to quickly find relevant tests. Each category entry features an overview and key highlights.
| Category | Sample Type | Turnaround Time | Clinical Utility |
|---|---|---|---|
| Transplant Diagnostics | Plasma, Whole Blood | 1–3 days | Rejection monitoring, HLA typing |
| Infectious Diseases | Serum, CSF, Swabs | 1–5 days | Pathogen identification |
| Autoimmune Profiles | Serum | 2–4 days | Autoantibody panels |
| Oncology Assays | FFPE, Blood | 5–10 days | Mutation analysis, MRD |
Transplant Diagnostics
The Transplant Diagnostics section provides tools for monitoring graft health and immune compatibility. Molecular assays measure donor-derived cell-free DNA to detect early rejection.
HLA antibody detection and epitope analysis guide donor selection. Regular monitoring helps tailor immunosuppressive regimens.
Donor-derived cell-free DNA assays deliver high sensitivity and specificity. These quantitative tests flag subtle increases in graft injury markers.
Combined with clinical data, they aid in prompt interventions. Strong evidence supports improved outcomes with early detection.
Infectious Disease Panels
Comprehensive infectious disease panels cover bacterial, viral, fungal, and parasitic pathogens. Multiplex PCR panels simplify diagnosis by detecting multiple targets in a single run.
Real-time PCR assays provide rapid turnaround times. Deep sequencing delivers insights into resistant strains and uncommon organisms.
Specialty assays include CMV viral load, BK viral load, and next-generation sequencing-based pathogen ID. These tests are critical for immunocompromised patients and outbreak investigations.
Results guide antimicrobial therapy and infection control measures. The laboratory offers accurate quantification and genotypic resistance data.
Autoimmune Profiles
Autoimmune profiles assess the presence of disease-specific autoantibodies. Panels include connective tissue disease, vasculitis, and neurological autoimmunity.
Tests leverage ELISA, immunofluorescence, and multiplex platforms. Interpretation guides immunomodulatory therapies.
Some panels feature reflex testing algorithms to reduce turnaround time and cost. Titers and patterns provide diagnostic clarity.
Clinical correlation is recommended for borderline results. The menu details specimen handling to preserve antibody integrity.
Oncology Assays
The Oncology Assays section encompasses molecular profiling, minimal residual disease (MRD) monitoring, and circulating tumor DNA (ctDNA) evaluations. Next-generation sequencing panels analyze actionable mutations across solid tumors and hematologic malignancies.
Results inform targeted therapy selection.
MRD assays use digital PCR and NGS to detect low-frequency variants. These sensitive tools help evaluate treatment response and relapse risk.
ctDNA tests enable noninvasive disease monitoring via blood draws. Analytical performance metrics are provided for each assay.
Ordering and Specimen Requirements
Ordering tests from Eurofins Viracor is streamlined via online requisitions or electronic interfaces. Each test listing includes a requisition code and specimen transport instructions.
Specimen integrity is critical for accurate results. Cold-chain shipping is available for time-sensitive assays.
Detailed collection instructions specify volume, container type, and additive requirements. For molecular assays, EDTA plasma or Streck tubes are recommended.
Serum separator tubes are used for serology. Reference ranges and storage conditions are provided to maintain sample stability.
Completed requisition forms should accompany specimens. Additional documentation may be required for custom testing protocols.
The client services team can assist with urgent courier arrangements. Tracking ensures timely delivery to the laboratory.
Result Interpretation and Reporting
Eurofins Viracor reports are structured with clear layouts featuring patient demographics, test results, and interpretive comments. Abnormal findings are highlighted in bold.
For quantitative assays, reference ranges and delta values are included. Technical notes explain assay limitations.
Interpretive comments provide clinical context and actionability. In complex cases, board-certified pathologists review and sign out reports.
Electronic health record integration accelerates provider access. Historical comparisons enable trend analysis over multiple time points.
“The level of detail in Viracor’s transplant reports has been invaluable for our care team. Early rejection detection has improved patient outcomes significantly.” – Transplant Specialist
Frequently Asked Questions
How do I access the test menu? Clients can download the PDF menu from the Eurofins Viracor website or request a printed copy.
Online portals allow real-time search of available assays.
What are the billing procedures? Eurofins Viracor offers direct billing to insurance or Medicare/Medicaid.
Self-pay options and pricing estimates are available upon request. Pre-authorization support is provided for complex cases.
Can I request new test development? Custom assay development is possible through the laboratory’s R&D collaboration program.
Turnaround times and feasibility are evaluated based on clinical need and technical requirements.
How are urgent samples handled? Stat and rush processing is available for critical cases.
Contact client services before shipment to arrange expedited testing. Additional fees may apply for rush services.
What quality certifications does Viracor hold? The laboratory maintains CLIA certification, CAP accreditation, and ISO 15189 compliance.
Regular proficiency testing ensures ongoing performance excellence.
Conclusion
The Eurofins Viracor Test Menu is a vital resource for clinicians managing complex medical conditions. Its breadth of specialized assays and rigorous quality standards provide actionable insights.
Clear ordering procedures, robust reporting, and expert support streamline laboratory interactions. By leveraging these advanced diagnostics, healthcare teams can enhance patient outcomes and deliver precision medicine at every stage.
For the most up-to-date test offerings and detailed instructions, visit the Eurofins Viracor website or contact your dedicated client services representative. Together, we can optimize diagnostic strategies and elevate patient care.
